First human test for new cholesterol drug begins
NCT ID NCT06452771
Summary
This is an early-stage study testing the safety of an experimental drug called ALN-ANG3 in healthy adults with high cholesterol. The main goal is to see what side effects might occur and how the drug moves through the body. Researchers will also check if the body develops any immune reactions to the drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS WITH HYPERLIPIDEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
New Zealand Clinical Research
Christchurch, Canterbury, 8013, New Zealand
Conditions
Explore the condition pages connected to this study.